SXR3:F:F-iShares VII Public Limited Company - iShares MSCI UK UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 183.22

Change

0.00 (0.00)%

Market Cap

USD 0.08B

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-07 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
SXR8:F iShares Core S&P 500 UCITS ETF..

N/A

USD 101.74B
UIM5:F UBS (Lux) Fund Solutions - MSC..

-0.18 (-0.35%)

USD 101.37B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

N/A

USD 96.03B
XDNY:F Xtrackers MSCI Japan ESG Scree..

-0.04 (-0.28%)

USD 57.02B
XJSE:F Xtrackers II - Japan Governmen..

-0.02 (-0.32%)

USD 53.72B
VUSA:F Vanguard Funds Public Limited ..

+0.29 (+0.31%)

USD 51.63B
SXRZ:F iShares VII PLC - iShares Nikk..

-1.85 (-0.80%)

USD 45.80B
0ZC:F Zscaler Inc

-3.20 (-1.54%)

USD 37.92B
BSND:F Danone SA

-0.20 (-1.35%)

USD 33.83B
VGWL:F Vanguard FTSE All-World UCITS ..

N/A

USD 24.77B

ETFs Containing SXR3:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 4.63% 75% C 69% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 4.63% 75% C 68% D+
Trailing 12 Months  
Capital Gain 7.47% 77% C+ 67% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 7.47% 74% C 59% D-
Trailing 5 Years  
Capital Gain 76.34% 75% C 70% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 76.34% 75% C 54% F
Average Annual (5 Year Horizon)  
Capital Gain 13.21% 82% B 72% C
Dividend Return 13.21% 80% B- 64% D
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 9.25% 70% C- 93% A
Risk Adjusted Return 142.81% 99% N/A 99% N/A
Market Capitalization 0.08B 28% F 28% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.